Story
Hims & Hers Stock Dips as Major Earnings Miss Overshadows Revenue Beat

Shares of Hims & Hers Health (NYSE: HIMS) slipped 1.5% in after-hours trading after the telehealth company reported second-quarter results that featured a significant earnings miss, overshadowing strong revenue growth and an increased full-year forecast.
Quarterly Results Breakdown
The company announced Q2 2026 revenue of $753 million, a 38% increase year-over-year that surpassed analyst expectations. However, this top-line strength was offset by a much wider-than-expected loss.
Hims & Hers posted a loss per share of -$0.37, missing the consensus estimate of a -$0.05 loss by a substantial margin. According to the company, the shortfall was driven by a 12-percentage-point contraction in gross margin, which it attributed to its ongoing transition from compounded to more expensive branded GLP-1 weight-loss medications.
Upgraded Outlook Fails to Lift Shares
Despite the profitability challenges, management provided an optimistic outlook for the remainder of the year. Hims & Hers raised its full-year 2026 revenue guidance to a range of $3.1 billion to $3.3 billion, up from a prior forecast of $2.8 billion to $3.0 billion and above the analyst consensus of $3.05 billion.
AdFor the upcoming third quarter, the company projects revenue between $880 million and $900 million, with adjusted EBITDA expected to be in the range of $75 million to $95 million.
Investor Concerns Weigh on Sentiment
Investors appeared to focus on the near-term profitability pressures and other headwinds. Before the report, Truist Securities had reiterated a Hold rating on the stock with a $27 price target. Furthermore, card data cited by Investing.com indicated that GLP-1 billings declined 1% month-over-month in July after expanding 32% in June, raising questions about near-term growth momentum.
A legal overhang also continues to weigh on the stock. Hims & Hers faces a lawsuit from the Federal Trade Commission filed in late July over allegations of sharing sensitive user health data, in addition to investigations from multiple law firms regarding alleged securities violations. The combination of the earnings miss, margin pressure, and unresolved legal risks appeared to outweigh the positive guidance in the market's initial reaction.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.